Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 21759 [2014-08760]

Download as PDF Federal Register / Vol. 79, No. 74 / Thursday, April 17, 2014 / Notices the same email address: OGA.RSVP@ hhs.gov. We look forward to hearing your comments relative to the 67th World Health Assembly agenda items. DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of Global Affairs: Stakeholder Listening Session in Preparation for the 67th World Health Assembly Time and date: May 9, 2014, 12:00– 1:30 p.m. EST. Place: Willow Conference Room, Thomas P. O’Neill Federal Building, 200 C St. SW., Washington, DC 20024. Status: Open, but requiring RSVP to OGA.RSVP@hhs.gov. Purpose The U.S. Department of Health and Human Services (HHS)—charged with leading the U.S. delegation to the 67th World Health Assembly—will hold an informal Stakeholder Listening Session on Friday, May 9, 12:00–1:30 p.m., in the Willow Conference Room of the Thomas P. O’Neill Federal Building, 200 C St. SW., Washington, DC 20024. The Stakeholder Listening Session will help the HHS Office of Global Affairs prepare for the World Health Assembly by taking full advantage of the knowledge, ideas, feedback, and suggestions from all communities interested in and affected by agenda items to be discussed at the 67th World Health Assembly. Your input will contribute to U.S. positions as we negotiate these important health topics with our international colleagues. The listening session will be organized around the interests and perspectives of stakeholder communities, including, but not limited to: • Public health and advocacy groups; • State, local, and Tribal groups; • Private industry; • Minority health organizations; and • Academic and scientific organizations. It will allow public comment on all agenda items to be discussed at the 67th World Health Assembly: https:// apps.who.int/gb/ebwha/pdf_files/ WHA67/A67_1-en.pdf. TKELLEY on DSK3SPTVN1PROD with NOTICES RSVP Due to security restrictions for entry into the HHS Thomas P. O’Neill Federal Building, we will need to receive RSVPs for this event. Please send your full name and organization to OGA.RSVP@ hhs.gov. If you are not a U.S. citizen, please note this in the subject line of your RSVP, and our office will contact you to gain additional biographical information for your clearance. Please RSVP no later than Friday, May 2, 2014. Written comments are welcome and encouraged, even if you are planning on attending in person. Please send these to VerDate Mar<15>2010 17:28 Apr 16, 2014 Jkt 232001 21759 DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: April 7, 2014. Jimmy Kolker, Assistant Secretary for Global Affairs. Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review [FR Doc. 2014–08396 Filed 4–16–14; 8:45 am] The meeting announced below concerns Research to Prevent Prescription Drug Overdoses, Funding Opportunity Announcement (FOA) CE14–002, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: BILLING CODE 4150–38–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Longitudinal Study of a Population-based Cohort of People with Lupus, Funding Opportunity Announcement (FOA) DP14–004, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 9:00 a.m.–6:00 p.m., EST, May 8, 2014 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Longitudinal Study of a Population-based Cohort of People with Lupus, FOA DP14–004, initial review.’’ Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F–80, Atlanta, Georgia 30341, Telephone: (770) 488–3585, EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–08762 Filed 4–16–14; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 Centers for Disease Control and Prevention Time and Date: 12:00 p.m.–4:00 p.m. EST, May 7, 2014 (Closed). Place: This meeting will be held via teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Research to Prevent Prescription Drug Overdoses, FOA CE14–002’’. Contact Person for More Information: Jane Suen, Dr.P.H., M.S., Scientific Review Officer, CDC, 4770 Buford Highway, NE., Mailstop F–63, Atlanta, Georgia 30341–3724, Telephone (770) 488–4281. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–08760 Filed 4–16–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Motor Vehicle Injury Prevention: Evaluation of Increased Nighttime Enforcement of Seatbelt Use, Funding Opportunity Announcement (FOA) CE14–003, initial review. E:\FR\FM\17APN1.SGM 17APN1

Agencies

[Federal Register Volume 79, Number 74 (Thursday, April 17, 2014)]
[Notices]
[Page 21759]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-08760]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Research to Prevent 
Prescription Drug Overdoses, Funding Opportunity Announcement (FOA) 
CE14-002, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 12:00 p.m.-4:00 p.m. EST, May 7, 2014 (Closed).
    Place: This meeting will be held via teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Research to Prevent Prescription Drug Overdoses, FOA 
CE14-002''.
    Contact Person for More Information: Jane Suen, Dr.P.H., M.S., 
Scientific Review Officer, CDC, 4770 Buford Highway, NE., Mailstop 
F-63, Atlanta, Georgia 30341-3724, Telephone (770) 488-4281.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2014-08760 Filed 4-16-14; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.